TP53 and prostate adenocarcinoma: TP53 Overexpression and Disease-Free Survival (DFS): Furthermore, our investigation extended to disease-free survival (DFS), uncovering TP53 overexpression as a predictor of poorer prognoses, notably observed in PRAD (refer to Figure 4b).